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Studies have indicated that partially unfolded states occur
under conditions that favor amyloid formation by
transthyretin (TTR), as well as other amyloidogenic proteins.
In this study, we used hydrogen exchange measurements to
show that there is selective destabilization of one half of the
β-sandwich structure of TTR under such conditions. This
provides more direct information about conformational
fluctuations than previously available, and will facilitate
design of future experiments to probe the intermediates crit-
ical to amyloid formation.
Amyloid fibril formation, or amyloidogenesis, is a process by
which a normally soluble protein undergoes conformational
changes and self-assembles into an insoluble fibril morphology
in vivo1,2. This is believed to cause neurodegenerative diseases3–6.
While the best known diseases associated with amyloidogenesis
are Alzheimer’s disease, light chain disease, and familial amyloid
polyneuropathies (FAPs), ∼20 biochemically diverse precursor
proteins, including transthyretin (TTR), are known to form
amyloid fibrils7,8. Studies have demonstrated that acidic condi-
tions accelerate TTR amyloid fibril formation by increasing the
extent of tetrameric TTR dissociating to form an assembly com-
petent, monomeric structure with an altered tertiary struc-
ture9,10. We have conducted deuterium-proton (D-H) exchange
experiments on the backbone amides of TTR under acidic con-
ditions, which cause an increase in the amount of the amyloido-
genic intermediate, to characterize regions of conformational
change. The regions of the protein destabilized under these con-
ditions are different and more extensive than previously thought,
involving the CBEF sheet that contains most of the disease asso-
ciated mutations.
TTR is found in human plasma (0.2 mg ml-1) as a homo-
tetramer of 127-residue subunits. The crystal structure of native
TTR reveals that each subunit has eight β-strands, A to H (Fig.
3a), arranged as a β-sheet sandwich with a hydrophobic core11.
The wild type (WT) tetramer is very stable to denaturation at
neutral pH12, yet, in certain individuals, it is converted into amy-
loid fibrils. WT-TTR amyloid formation is associated with the
disease senile systemic amyloidosis (SSA), whereas ∼70 single site
variants are associated with FAPs13,14. While FAPs affect only one
in 105–106 individuals, SSA affects 25% of the population over 80
years of age15,16. The accelerated amyloidogenesis in FAPs sug-
gests that small structural perturbations can destabilize the
native structure, enhancing the formation of the amyloidogenic
intermediates17,18.
The very nature of amyloids poses an intriguing problem; the
20 amyloidogenic proteins exhibit little homology in sequence or
structure, yet all form amyloid fibrils of a similar overall struc-
ture15. One explanation for this phenomenon may be that the
similarity among the amyloidogenic proteins develops not at the
level of their normally folded structures, but rather the common
structural features arise under partially denaturing conditions,
which generate amyloidogenic intermediates19. Understanding
the conditions that promote the accumulation of amyloidogenic
intermediates, as well as their underlying common structural
features, should provide further information about amyloidoge-
nesis in general. Recent biophysical studies on TTR have identi-
fied in vitro conditions that stimulate amyloid formation9,10,20
(Fig. 1).
Isolated WT-TTR remains stable and tetrameric from pH 7 to
pH 5 and does not form amyloid. However, over the pH range of
5.0–3.9, TTR dissociates to a monomer that exhibits an altered
but defined tertiary structure, as probed by fluorescence and far
and near UV circular dichroism. The extent of amyloidogenesis
correlates with the concentration of amyloidogenic monomer,
which is maximal at pH 4.49,10. Upon further acidification 
(< pH 3.9), the structurally defined monomers adopt alterna-
tive conformations analogous to a molten globule-like acid-
denatured state (A-state), which forms low molecular weight
A-state aggregates but not amyloid fibrils21. These observations
suggest that amyloidogenesis results from interactions between
specific structural elements of alternatively folded TTR
monomers. Here we report the results of deuterium-proton 
(D-H) exchange experiments22–24 on WT-TTR at pH 5.75 (non-
amyloidogenic tetramer) and 4.5 (amyloidogenic monomer),
monitored by two-dimensional NMR spectroscopy, that pro-
vide site specific information complementing previous mass
spectroscopic studies18. The differences in the backbone amide
D-H exchange rates under these two conditions reveal that one
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Fig. 1 The pathway of TTR denaturation and amyloid fibril formation.
Tetrameric TTR dissociates into monomers with an altered structure (pos-
sibly through dimers first) at pH 4.5 that are capable of amyloid forma-
tion. Upon further acidification, TTR monomers are converted into the
A-state, which is not amyloidogenic. TTR denaturation and amyloid fibril
formation are competitive processes that share a common monomeric
amyloidogenic intermediate.
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side of the β-sheet sandwich (strands C, B, E,  and F) is destabi-
lized under conditions favoring the formation of the amyloido-
genic intermediate. We suggest that this region of the protein is
destabilized by the effects of pH changes and mutations, and
loses its native contacts with the core β-sheet fold in the amy-
loidogenic intermediate.
The backbone amide 1H-15N resonances of 118 out of 120
nonproline residues in tetrameric WT-TTR were assigned by
NMR using uniformly 2H, 13C and 15N labeled samples25. In D-H
exchange experiments, protected amide hydrogens are generally
involved in hydrogen bonds. The crystal structure suggests that
there are 59 amide hydrogen bonds within each monomer, with
44 in the β-sheet region and the helix11 (Fig. 3a). At pH 5.75 
(>0.2 mg ml-1 TTR), when TTR is predominantly tetrameric, we
found that 41 amide hydrogens were completely, and 14 were
partially, protected from exchange after 2 h. These amides are
mainly located in the two β-sheets and serve as probes to map
the changes that occur under conditions that cause an increase in
the population of the amyloidogenic intermediate.
Our D-H exchange experiments commenced with concentrat-
ed perdeuterated TTR solutions, which were diluted into H2O at
pH 4.5 or pH 5.75. Dilution to 0.008 mg ml-1 shifts the equilibri-
um from tetramer to monomer while inhibiting irreversible
assembly into amyloid. After different incubation periods, both
samples were adjusted to pH 5.75, to reform the tetramer, allow-
ing the protein to be concentrated for NMR detection of the 1H-
15N resonances. Starting with deuterated TTR (2H-15N), any
signals reflect the exchange-in of protons from H2O. SDS-PAGE
analysis, analytical ultracentrifugation and gel-filtration studies
of TTR at 0.005–0.01 mg ml-1 in the buffers used showed that
about 75% of TTR is monomeric at pH 4.5, while 25% is
monomeric at pH 5.75, consistent with previous results10. D-H
exchange data collected at pH 5.75, with the protein in a non-
amyloidogenic state, gave very similar exchange patterns at both
high (10 mg ml-1) and low (0.008 mg ml-1) concentrations of
TTR. These data demonstrate that even if TTR dissociates to the
monomeric state at low concentration its structure remains
native like at pH 5.75, consistent with previous observations10.
Differences in the D–H exchange patterns at pH 4.5 and 5.75
should therefore reflect structural changes that occur under
amyloidogenic conditions.
This comparison unambiguously revealed increased exchange
rates for the backbone amides of Ser 23, Val 30, His 31, Val 32,
Phe 33, Arg 34, Lys 35, Glu 42, Tyr 69, Val 71, Glu 72, Val 93, and
Phe 95 (Fig. 2 and 3b) at the lower pH. Note that intrinsic D-H
exchange rates are pH dependent, following V-shaped log (rate)
versus pH curves, with minima between pH 3 and 4 (ref. 26).
Accordingly, intrinsic D-H exchange rates are >10 times faster at
pH 5.75 than at pH 4.5. In addition, the exchange rates of the
more stable amides from both sheets, including those in strands
A, B, E, G, and Glu 42 from strand C, are very similar to one
another at high protein concentration (10 mg ml-1) and pH 5.75.
Consequently, the increased exchange rates at pH 4.5, observed
for the aforementioned 13 residues, must be caused by disrup-
tion of hydrogen bonds. All of the amides deprotected at pH 4.5,
except Ser 23, are involved in interstrand hydrogen bonds in the
tetramer (pH 5.75) and are located within the C, B, E,  and F
strands (CBEF sheet) of the β-sandwich (Fig. 3).
This study identifies the residues that undergo increased con-
formational fluctuations under amyloidogenic conditions, and
leads to unexpected conclusions. Previous thinking about struc-
tural changes in the amyloidogenic intermediate, based on low
resolution spectroscopic data, suggested that TTR amyloidogen-
esis begins with dissociation of tetramer followed by separation
of β-strands C and D from the core of the monomer9,10,14,19,27.
Our study reveals that all hydrogen bonds connecting β-strands
B and C are destabilized, while those connecting β-strands D and
A remain partially intact. Interestingly, the amides on β-strand A
remain protected but those defining β-strand D exchange, indi-
cating that there is local labilization. The inherent instability of
this region is indicated by the fact that β-strand C (Ala 45,
Gly 47) and β-strand D (Leu 55) amides undergo relatively rapid
exchange even at pH 5.75. However, under native conditions, 
β-strands C and D remain connected to β-strands A and B
through hydrogen bonds donated by the latter strands and one
donated by β-strand C (Glu 45).
In addition to disruptions of hydrogen bonds connecting 
β-strands B and C at pH 4.5, we observed similar effects on
hydrogen bonds connecting β-strands B to E, and E to F. Such
disruptions are likely concurrent, suggesting a cooperative dis-
ruption of half of the β-sandwich, the sheet composed of the B,
C, E, and F strands. Although this region is destabilized, the
exchange rates of the residues do not increase enough to equal
those of fully exposed residues; the protection factors decrease
dramatically, but the most highly populated structure probably
still contains native-like hydrogen bonds. Under the acidic con-
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Fig. 2 D-H exchange monitored
by NMR. HSQC spectra taken at
pH 5.75 (40 °C) with samples re-
concentrated to 10 mg ml-1 after
6 h incubation at 0.008 mg ml-1.
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ditions, many more fluctuations occur to states in which the C,
B, E, and F strands are unfolded than to the totally unfolded
state. The fact that amyloidogenicity increases under conditions
that give rise to such an intermediate state, but drops again under
conditions favoring full unfolding, argues that a partially unfold-
ed intermediate is important for generation of amyloid.
Such a partially unfolded state could facilitate the formation of
intermolecular interactions that are essential for amyloidogene-
sis. Interestingly, there are pathogenic variants at many residue
positions that are protected by hydrogen bonds in the native fold
for the wild type sequence (pH 5.75), but become deprotected
under amyloidogenic conditions (pH 4.5). Importantly, there are
more pathogenic mutations within β-strands of the CBEF sheet
than on the other β-sheet of the sandwich (DAGH), which is the
location of most of the nonpathogenic variants (Fig. 3b). It is
presently impossible to dissect the effects of mutations on stabil-
ity. In most proteins, mutations generally result in a decrease in
global stability. However, it seems likely that in partially unfold-
ed states, such as the intermediate, the destabilization will be
more localized to the region around the site of the mutation. The
distribution of TTR variants thus also suggests that destabilizing
β-strands of the CBEF sheet is crucial for TTR amyloidogene-
sis14,16. Future hydrogen exchange measurements on pathogenic
variants can help clarify such a relationship by detecting changes
in localized destabilization.
At both pH 4.5 and pH 5.75, residues 12–25, as well as Ile 107
and Leu 111, remain protected against D–H exchange. This indi-
cates that β-strand A is anchored to β-strand G through well pro-
tected hydrogen bonds and maps out the core of TTR that
remains unaltered even under amyloidogenic conditions (Fig. 3).
Amyloidogenic conditions thus appear to stimulate changes in
only part of the molecule, rather than causing global unfolding10.
The D–H exchange under amyloidogenic conditions has been
studied at the whole protein level by mass spectroscopy18. That
study established that there are ~60 amides in the whole WT-
TTR protected against exchange, but could not identify the
residues involved. This number is close to the number of amides
detected in our NMR experiments. It was also found that the
number of amides protected dropped to ~20 in the V30M vari-
ant, which is more amyloidogenic. The reduction in the number
of protected amides between WT-TTR and the V30M variant is
greater than that between WT-TTR at neutral and low pH.
Intrinsic differences in the techniques, site specific for NMR but
molecule averaged for mass spectroscopy, make quantitative
comparisons of partial exchange difficult.
Our data demonstrate that the pH dependent changes that
occur under conditions giving rise to the monomeric amyloido-
genic intermediate are best characterized as a destabilization and
increase in mobility of the CBEF β-sheet. The wide distribution
of sites in the protein and variety of pathogenic variants suggest
that their enhanced amyloidogenesis is not due to local structur-
al perturbations, but rather results from destabilization of the
tertiary fold. Furthermore, the preponderance of FAP associated
variants on one side of the β-sheet sandwich, coupled with the
D-H exchange data at pH 4.5 suggests that conformational
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Fig. 3 The low pH conformational changes in TTR. a, Ribbon diagram rep-
resentation of a TTR monomer in the native state (prepared using MOL-
MOL30) with β-strands labeled A through H11. Regions highlighted in
magenta contain amide hydrogens more labile at pH 4.5 than at pH 5.75.
Color coded bars indicate amide hydrogens protected at pH 5.75 and
10 mg ml-1 TTR that were used as probes for intermediate states of TTR:
orange, NHs partially exchanged after 72 h at pH 5.75 and 10 mg ml-1 TTR;
blue, NHs protected for more than 500 h at the same conditions; magen-
ta, same as blue, but NHs do exchange at pH 4.5 and 0.008 mg ml-1 TTR. 
b, Schematic diagram of TTR consisting of one TTR monomer and the H
strand of a neighboring monomer. Boxes indicate native state β-strands
labeled A through H. Arrows indicate backbone hydrogen bonds pointing
from donor to the acceptor residue. Only residues in secondary structure
elements or protected at pH 5.75 are shown. The residue labels are color
coded according to the exchange behavior at pH 5.75 and 20 mg ml-1 TTR.
Green, NHs are completely exchanged after 2 h; orange, NHs are partially
exchanged after 72 h; blue, NHs are protected for more than 500 h; black,
either Pro or the unassigned Ala 120. The 1H-15N of Ala 108, which was
assigned although it is very broad and not useful as a D–H exchange
probe, is also labeled in black. Residues underlined with black bars have
pathogenic variants, and residues underlined with cyan bars have non-
pathogenic variants. Magenta colored bars highlight residues of TTR that
are deprotected under amyloidogenic conditions (pH 4.5) and correspond
to the magenta hydrogen bonds in (a). The area shaded in blue indicates
residues that remain protected under all conditions tested.
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changes involve β-strands CBEF and possibly cause displace-
ment of the CBEF sheet from the core of the β-sandwich. The
disruption of these four strands would expose hydrogen bond
donors and acceptors as well as hydrophobic patches that enable
self-assembly of the amyloidogenic intermediate, ultimately
causing formation of amyloid fibrils28,29.
Methods
Per-deuteration of TTR amide groups. 2H and 15N labeled TTR
was produced in Escherichia coli in D2O and 15NH4Cl defined media,
and purified as described17. The lyophilized TTR powder was dis-
solved in D2O solution at 0.25 mg ml-1 and adjusted to pH 2.0 with
DCl. At pH 2.0, TTR is a random coil that allows complete exchange
of its amide hydrogens with the solvent20. TTR was exchanged for
over 12 h at room temperature to allow complete deuteration. The
protein was then diluted four-fold with D2O, and neutralized to pH
6.0 with NaOD to initiate refolding of TTR. Dilution was necessary to
reduce protein aggregation during refolding. Renatured TTR was
centrifuged to remove precipitate, and was then used in hydrogen
exchange experiments.
Deuterium-proton exchange at pH 4.5. 2H-15N doubly labeled
TTR stock solution (0.25 mg ml-1) was diluted into H2O containing
5 mM KH2PO4 to a concentration of 0.008 mg ml-1, and the pH
adjusted with HCl to 4.5. The solution was kept at 37 °C for different
periods of time. Concentrated buffer was then introduced to bring
TTR back to the native state. The final solution was at pH 5.75 
(50 mM phosphate and 100 mM NaCl). The TTR solution was con-
centrated to 0.4 mg ml-1 within 2 h by a MiniKros® Sampler System
(MICROGON). Before NMR studies, further concentration to 
10 mg ml-1 was carried out using Amicon Centriprep and Centricon
filters.
Deuterium–proton exchange at pH 5.75. The same procedure
was performed as above, except that TTR was kept at pH 5.75
throughout the entire process.
SDS-PAGE analysis. SDS-PAGE was performed with a gradient gel
(10–20%) and silver stained. Tetrameric TTR in SDS loading buffer
without boiling produces a 30 kDa band (dimer) while monomeric
TTR runs as a 14 kDa band.
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